NCT05548712

Brief Summary

Health care costs are increasing alarmingly, which will impose an overwhelming economic burden to an aging society like that of Hong Kong. For example, degenerative musculoskeletal disorders such as osteoarthritis (OA) present a grand challenge with its high prevalence (\>40% in the elderly suffered from knee OA). OA is a debilitating progressive disease with typical symptoms such as acute pain causing loss of mobility Currently there is no cure for OA. Pharmacological treatment and new regenerative technologies such as stem cell therapy are actively being developed, but most of these options are very expensive per se, and side effects are not uncommon. Costeffectiveness is also a major consideration for devising new therapeutic modalities for OA. There are emerging evidences showing that pulsed electromagnetic field (PEMF) can modulae mitochondrial activities for muscle gain. PEMF exposure on top of regular exercise training may promote muscle regeneration and tissue healing. This study aims to conduct a double-blinded, randomized controlled trial to investigate the effect of PEMF treatment on knee pain in patients with knee OA. We hypothesize that PEMF treatment is effective to relief in pain and improve knee function in Knee OA subjects. Based on the aim of this study, older adult patients (aged 50 or above) with knee OA with Kellgren-Lawrence grade 2-4 by X-ray, have sedentary lifestyle (Tegner activity level less or equal to 3), no acute knee injuries in past 12 months, no muscle strain in past 12 months and not degenerative joint disease in other joints except the involved knee. To estimate the improvement of patients, isometric quadricep muscle strength, posture assessment, serum myokine level, serum vitamin D level and selfreported outcome with questionnaires will be performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started May 2022

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2024

Completed
Last Updated

December 20, 2023

Status Verified

December 1, 2023

Enrollment Period

2.4 years

First QC Date

August 12, 2022

Last Update Submit

December 13, 2023

Conditions

Keywords

Pulse electromagnetic fieldPEMFKnee OsteoarthritisKnee OAKnee pain

Outcome Measures

Primary Outcomes (1)

  • Change of Peak torque of Isometric muscle strength

    The peak torque in kgf will be recorded with in 2 trials in the 5 seconds isometric muscle strength test.

    pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF

Secondary Outcomes (11)

  • International Physical Activity Questionnaire

    pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF

  • Tegner activity score

    pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF

  • Short Form-36 questionnaires (SF-36)

    pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF

  • Serum myokine evaluation

    pre PEMF treatment, 3-months, 6-months, and 12-months after the commencement of PEMF

  • The speed and rate of force development in 6 repetitions in chair stand test

    pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF

  • +6 more secondary outcomes

Study Arms (2)

Treatment group

EXPERIMENTAL
Device: Pulse Electromagnetic Field

Sham group

SHAM COMPARATOR
Device: Sham Pulse Electromagnetic Field

Interventions

Subjects will receive PEMF treatment with the duration of 8 weeks, twice a week with total 16 treatment sessions and do the home-based exercise twice a week for 8 weeks.

Treatment group

Subjects will receive sham PEMF treatment with the duration of 8 weeks, twice a week with total 16 treatment sessions and do the home-based exercise twice a week for 8 weeks.

Sham group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 50 or above
  • knee OA with Kellgren-Lawrence grade 2-4 by X-ray
  • Sedentary lifestyle (Tegner activity level ≤ 3)
  • No acute knee injuries in past 12 months
  • No muscle strain in past 12 months
  • No degenerative joint diseases in other joints except the involved knee

You may not qualify if:

  • Age smaller than 50 years old
  • Experienced any concomitant bone fracture, ACL injury, major meniscus injury
  • Any rheumatological diseases
  • Metal implants that would cause interference on MRI
  • Previous contralateral knee injury
  • Recent knee injections (prior 3 months)
  • Physical inability to undertake testing procedures
  • Pregnancy or possibility of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Michael Tim-Yun Ong

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Tim-Yun Ong

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
It is doubled blinded, a subject 's specific ID card will be provided for each of the enrolled subject and the investigators don't know whether it is PEMF or Sham treatment for that subject's specific ID card. And the investigator will ask the manufactory about the number of grouping at the end of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be assigned into either treatment group or sham group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

August 12, 2022

First Posted

September 21, 2022

Study Start

May 5, 2022

Primary Completion

September 15, 2024

Study Completion

September 15, 2024

Last Updated

December 20, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
starting 6 months after publication
Access Criteria
Journal reviewers

Locations